IGFBP4 Antikörper (C-Term)
-
- Target Alle IGFBP4 Antikörper anzeigen
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human, Maus, Rind (Kuh)
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser IGFBP4 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Sequenz
- KGELDCHQLA DSFRE
- Aufreinigung
- Affinity purification
- Immunogen
- C-terminal
- Isotyp
- IgG
- Top Product
- Discover our top product IGFBP4 Primärantikörper
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
- Buffer
- 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin. Aliquot and store at -20 °C. Minimize freezing and thawing.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
-
- Target
- IGFBP4 (Insulin-Like Growth Factor Binding Protein 4 (IGFBP4))
- Andere Bezeichnung
- IGFBP4 (IGFBP4 Produkte)
- Synonyme
- IGFBP4 antikoerper, igfbp4 antikoerper, BP-4 antikoerper, HT29-IGFBP antikoerper, IBP4 antikoerper, IGFBP-4 antikoerper, AI875747 antikoerper, Deb2 antikoerper, IGF-BP4 antikoerper, IBP-4 antikoerper, insulin like growth factor binding protein 4 antikoerper, insulin-like growth factor-binding protein 4 antikoerper, insulin-like growth factor binding protein 4 antikoerper, IGFBP4 antikoerper, LOC100136305 antikoerper, LOC100194498 antikoerper, igfbp4 antikoerper, Igfbp4 antikoerper
- Pathways
- WNT Signalweg, Myometrial Relaxation and Contraction, Regulation of Carbohydrate Metabolic Process
-